Liposomal Bupivacaine Market - Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: L4E1C8990D2BEN
Market Monitor Global

Abstracts

Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy.

This report contains market size and forecasts of Liposomal Bupivacaine in global, including the following market information:

Global Liposomal Bupivacaine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Liposomal Bupivacaine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Liposomal Bupivacaine companies in 2021 (%)

The global Liposomal Bupivacaine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

20ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liposomal Bupivacaine include Pacira Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomal Bupivacaine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liposomal Bupivacaine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Liposomal Bupivacaine Market Segment Percentages, by Type, 2021 (%)

• 20ml
• 10ml

Global Liposomal Bupivacaine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Liposomal Bupivacaine Market Segment Percentages, by Application, 2021 (%)

• Veterinary
• Human

Global Liposomal Bupivacaine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Liposomal Bupivacaine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liposomal Bupivacaine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Liposomal Bupivacaine revenues share in global market, 2021 (%)

Key companies Liposomal Bupivacaine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Liposomal Bupivacaine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pacira Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liposomal Bupivacaine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liposomal Bupivacaine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIPOSOMAL BUPIVACAINE OVERALL MARKET SIZE

2.1 Global Liposomal Bupivacaine Market Size: 2021 VS 2028
2.2 Global Liposomal Bupivacaine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Liposomal Bupivacaine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Liposomal Bupivacaine Players in Global Market
3.2 Top Global Liposomal Bupivacaine Companies Ranked by Revenue
3.3 Global Liposomal Bupivacaine Revenue by Companies
3.4 Global Liposomal Bupivacaine Sales by Companies
3.5 Global Liposomal Bupivacaine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Liposomal Bupivacaine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Liposomal Bupivacaine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomal Bupivacaine Players in Global Market
  3.8.1 List of Global Tier 1 Liposomal Bupivacaine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Liposomal Bupivacaine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Liposomal Bupivacaine Market Size Markets, 2021 & 2028
  4.1.2 20ml
  4.1.3 10ml
4.2 By Type - Global Liposomal Bupivacaine Revenue & Forecasts
  4.2.1 By Type - Global Liposomal Bupivacaine Revenue, 2017-2022
  4.2.2 By Type - Global Liposomal Bupivacaine Revenue, 2023-2028
  4.2.3 By Type - Global Liposomal Bupivacaine Revenue Market Share, 2017-2028
4.3 By Type - Global Liposomal Bupivacaine Sales & Forecasts
  4.3.1 By Type - Global Liposomal Bupivacaine Sales, 2017-2022
  4.3.2 By Type - Global Liposomal Bupivacaine Sales, 2023-2028
  4.3.3 By Type - Global Liposomal Bupivacaine Sales Market Share, 2017-2028
4.4 By Type - Global Liposomal Bupivacaine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liposomal Bupivacaine Market Size, 2021 & 2028
  5.1.2 Veterinary
  5.1.3 Human
5.2 By Application - Global Liposomal Bupivacaine Revenue & Forecasts
  5.2.1 By Application - Global Liposomal Bupivacaine Revenue, 2017-2022
  5.2.2 By Application - Global Liposomal Bupivacaine Revenue, 2023-2028
  5.2.3 By Application - Global Liposomal Bupivacaine Revenue Market Share, 2017-2028
5.3 By Application - Global Liposomal Bupivacaine Sales & Forecasts
  5.3.1 By Application - Global Liposomal Bupivacaine Sales, 2017-2022
  5.3.2 By Application - Global Liposomal Bupivacaine Sales, 2023-2028
  5.3.3 By Application - Global Liposomal Bupivacaine Sales Market Share, 2017-2028
5.4 By Application - Global Liposomal Bupivacaine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liposomal Bupivacaine Market Size, 2021 & 2028
6.2 By Region - Global Liposomal Bupivacaine Revenue & Forecasts
  6.2.1 By Region - Global Liposomal Bupivacaine Revenue, 2017-2022
  6.2.2 By Region - Global Liposomal Bupivacaine Revenue, 2023-2028
  6.2.3 By Region - Global Liposomal Bupivacaine Revenue Market Share, 2017-2028
6.3 By Region - Global Liposomal Bupivacaine Sales & Forecasts
  6.3.1 By Region - Global Liposomal Bupivacaine Sales, 2017-2022
  6.3.2 By Region - Global Liposomal Bupivacaine Sales, 2023-2028
  6.3.3 By Region - Global Liposomal Bupivacaine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Liposomal Bupivacaine Revenue, 2017-2028
  6.4.2 By Country - North America Liposomal Bupivacaine Sales, 2017-2028
  6.4.3 US Liposomal Bupivacaine Market Size, 2017-2028
  6.4.4 Canada Liposomal Bupivacaine Market Size, 2017-2028
  6.4.5 Mexico Liposomal Bupivacaine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Liposomal Bupivacaine Revenue, 2017-2028
  6.5.2 By Country - Europe Liposomal Bupivacaine Sales, 2017-2028
  6.5.3 Germany Liposomal Bupivacaine Market Size, 2017-2028
  6.5.4 France Liposomal Bupivacaine Market Size, 2017-2028
  6.5.5 U.K. Liposomal Bupivacaine Market Size, 2017-2028
  6.5.6 Italy Liposomal Bupivacaine Market Size, 2017-2028
  6.5.7 Russia Liposomal Bupivacaine Market Size, 2017-2028
  6.5.8 Nordic Countries Liposomal Bupivacaine Market Size, 2017-2028
  6.5.9 Benelux Liposomal Bupivacaine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Liposomal Bupivacaine Revenue, 2017-2028
  6.6.2 By Region - Asia Liposomal Bupivacaine Sales, 2017-2028
  6.6.3 China Liposomal Bupivacaine Market Size, 2017-2028
  6.6.4 Japan Liposomal Bupivacaine Market Size, 2017-2028
  6.6.5 South Korea Liposomal Bupivacaine Market Size, 2017-2028
  6.6.6 Southeast Asia Liposomal Bupivacaine Market Size, 2017-2028
  6.6.7 India Liposomal Bupivacaine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Liposomal Bupivacaine Revenue, 2017-2028
  6.7.2 By Country - South America Liposomal Bupivacaine Sales, 2017-2028
  6.7.3 Brazil Liposomal Bupivacaine Market Size, 2017-2028
  6.7.4 Argentina Liposomal Bupivacaine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Liposomal Bupivacaine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Liposomal Bupivacaine Sales, 2017-2028
  6.8.3 Turkey Liposomal Bupivacaine Market Size, 2017-2028
  6.8.4 Israel Liposomal Bupivacaine Market Size, 2017-2028
  6.8.5 Saudi Arabia Liposomal Bupivacaine Market Size, 2017-2028
  6.8.6 UAE Liposomal Bupivacaine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pacira Pharmaceuticals
  7.1.1 Pacira Pharmaceuticals Corporate Summary
  7.1.2 Pacira Pharmaceuticals Business Overview
  7.1.3 Pacira Pharmaceuticals Liposomal Bupivacaine Major Product Offerings
  7.1.4 Pacira Pharmaceuticals Liposomal Bupivacaine Sales and Revenue in Global (2017-2022)
  7.1.5 Pacira Pharmaceuticals Key News

8 GLOBAL LIPOSOMAL BUPIVACAINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Liposomal Bupivacaine Production Capacity, 2017-2028
8.2 Liposomal Bupivacaine Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomal Bupivacaine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LIPOSOMAL BUPIVACAINE SUPPLY CHAIN ANALYSIS

10.1 Liposomal Bupivacaine Industry Value Chain
10.2 Liposomal Bupivacaine Upstream Market
10.3 Liposomal Bupivacaine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Liposomal Bupivacaine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Liposomal Bupivacaine in Global Market
Table 2. Top Liposomal Bupivacaine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Liposomal Bupivacaine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Liposomal Bupivacaine Revenue Share by Companies, 2017-2022
Table 5. Global Liposomal Bupivacaine Sales by Companies, (K Units), 2017-2022
Table 6. Global Liposomal Bupivacaine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Liposomal Bupivacaine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Liposomal Bupivacaine Product Type
Table 9. List of Global Tier 1 Liposomal Bupivacaine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Bupivacaine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liposomal Bupivacaine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Liposomal Bupivacaine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Liposomal Bupivacaine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Liposomal Bupivacaine Sales (K Units), 2017-2022
Table 15. By Type - Global Liposomal Bupivacaine Sales (K Units), 2023-2028
Table 16. By Application – Global Liposomal Bupivacaine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Liposomal Bupivacaine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Liposomal Bupivacaine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Liposomal Bupivacaine Sales (K Units), 2017-2022
Table 20. By Application - Global Liposomal Bupivacaine Sales (K Units), 2023-2028
Table 21. By Region – Global Liposomal Bupivacaine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Liposomal Bupivacaine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Liposomal Bupivacaine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Liposomal Bupivacaine Sales (K Units), 2017-2022
Table 25. By Region - Global Liposomal Bupivacaine Sales (K Units), 2023-2028
Table 26. By Country - North America Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Liposomal Bupivacaine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Liposomal Bupivacaine Sales, (K Units), 2017-2022
Table 29. By Country - North America Liposomal Bupivacaine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Liposomal Bupivacaine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Liposomal Bupivacaine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Liposomal Bupivacaine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Liposomal Bupivacaine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Liposomal Bupivacaine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Liposomal Bupivacaine Sales, (K Units), 2023-2028
Table 38. By Country - South America Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Liposomal Bupivacaine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Liposomal Bupivacaine Sales, (K Units), 2017-2022
Table 41. By Country - South America Liposomal Bupivacaine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Liposomal Bupivacaine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Liposomal Bupivacaine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Liposomal Bupivacaine Sales, (K Units), 2023-2028
Table 46. Pacira Pharmaceuticals Corporate Summary
Table 47. Pacira Pharmaceuticals Liposomal Bupivacaine Product Offerings
Table 48. Pacira Pharmaceuticals Liposomal Bupivacaine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Liposomal Bupivacaine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Liposomal Bupivacaine Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Liposomal Bupivacaine Production by Region, 2017-2022 (K Units)
Table 52. Global Liposomal Bupivacaine Production by Region, 2023-2028 (K Units)
Table 53. Liposomal Bupivacaine Market Opportunities & Trends in Global Market
Table 54. Liposomal Bupivacaine Market Drivers in Global Market
Table 55. Liposomal Bupivacaine Market Restraints in Global Market
Table 56. Liposomal Bupivacaine Raw Materials
Table 57. Liposomal Bupivacaine Raw Materials Suppliers in Global Market
Table 58. Typical Liposomal Bupivacaine Downstream
Table 59. Liposomal Bupivacaine Downstream Clients in Global Market
Table 60. Liposomal Bupivacaine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Liposomal Bupivacaine Segment by Type
Figure 2. Liposomal Bupivacaine Segment by Application
Figure 3. Global Liposomal Bupivacaine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liposomal Bupivacaine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposomal Bupivacaine Revenue, 2017-2028 (US$, Mn)
Figure 7. Liposomal Bupivacaine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Liposomal Bupivacaine Revenue in 2021
Figure 9. By Type - Global Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 10. By Type - Global Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Liposomal Bupivacaine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 13. By Application - Global Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Liposomal Bupivacaine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 16. By Region - Global Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 19. US Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 24. Germany Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 25. France Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 33. China Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 37. India Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 40. Brazil Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Liposomal Bupivacaine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Liposomal Bupivacaine Sales Market Share, 2017-2028
Figure 44. Turkey Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Liposomal Bupivacaine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Liposomal Bupivacaine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Liposomal Bupivacaine by Region, 2021 VS 2028
Figure 50. Liposomal Bupivacaine Industry Value Chain
Figure 51. Marketing Channels